| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88221046 | FILING DATE | 12/07/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | GILBERT, HANNAH B |
L.O. ASSIGNED | N30-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 04/28/2020 | ||
| PUB DATE | 04/16/2019 | ||
| STATUS | 731-SECOND EXTENSION - GRANTED | ||
| STATUS DATE | 04/24/2020 | ||
| LITERAL MARK ELEMENT | XIPERE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | XIPERE |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Clearside Biomedical, Inc. |
| ADDRESS | 900 North Point Parkway, Suite 200 Alpharetta, GA 30005 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Ocular pharmaceuticals; Ophthalmic preparations |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of the word "XIPERE" beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter "I" and continuing through the center of the letters "P", "E", and ending at the bottom of the letter "R" followed by a capital "E". |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 04/28/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 021 |
| 04/24/2020 | EX2G | S | EXTENSION 2 GRANTED | 020 |
| 04/24/2020 | EXT2 | S | EXTENSION 2 FILED | 019 |
| 04/24/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 018 |
| 12/05/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 017 |
| 12/03/2019 | EX1G | S | EXTENSION 1 GRANTED | 016 |
| 12/03/2019 | EXT1 | S | EXTENSION 1 FILED | 015 |
| 12/03/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 014 |
| 06/11/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 013 |
| 04/16/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 012 |
| 04/16/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 011 |
| 03/27/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 010 |
| 03/12/2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 009 |
| 03/12/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 008 |
| 03/07/2019 | DOCK | D | ASSIGNED TO EXAMINER | 007 |
| 01/01/2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 006 |
| 12/30/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 005 |
| 12/20/2018 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 004 |
| 12/20/2018 | ALIE | A | ASSIGNED TO LIE | 003 |
| 12/18/2018 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 002 |
| 12/11/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Bassam N. Ibrahim |
| CORRESPONDENCE ADDRESS | Bassam N. Ibrahim BUCHANAN INGERSOLL & ROONEY, PC Suite 500 1737 King Street ALEXANDRIA VA 22314 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Clearside Biomedical, Inc. |
| ADDRESS | 900 North Point Parkway, Suite 200 Alpharetta, GA 30005 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |